Search       
 

About CLP
Contact Us
Subscribe
Read Weekly eNewsletter
HOME | NEWS | CURRENT ISSUE | BUYER'S GUIDE | ARCHIVES | CALENDAR | RESOURCES | CAREERS

Top News

Page 1 of 368


Updated Autism Test From CombiMatrix Gains Foothold    Jul 23, 2008
Ofatumumab promising in refractory follicular lymphoma    Jul 22, 2008
NEW YORK (Reuters Health) - The human monoclonal antibody ofatumumab was well tolerated by patients with relapsed or refractory follicular non-Hodgkin's lymphoma in a Phase 1 / 2 safety and efficacy trial, according to European researchers.
Most foreign-born TB patients in US from sub-Saharan Africa, SE Asia    Jul 22, 2008
NEW YORK (Reuters Health) - Between 2001-2006, 53% of the tuberculosis cases that occurred among foreign-born individuals in the US involved persons from sub-Saharan Africa or Southeast Asia, new research indicates.
Low mass islet cell transplants achieve insulin independence    Jul 22, 2008
NEW YORK (Reuters Health) - Allogeneic islet cell transplantation outcome is improved with smaller transplant size and with addition of etanercept and exenatide to the post-transplant immunosuppression regimen.
U.S. FDA, CDC say Merck's Gardasil shot remains safe    Jul 22, 2008
WASHINGTON (Reuters) - A review of health problems reported after women and girls received Merck & Co's Gardasil vaccine shows it remains safe and effective for protecting against a virus that causes cervical cancer, U.S. officials said on Tuesday.
CMV reactivation common in critically ill, immunocompetent patients    Jul 22, 2008
NEW YORK (Reuters Health) - Critically ill patients with intact immune systems frequently experience cytomegalovirus (CMV) reactivation, with the reactivation independently linked to prolonged hospitalization or death.
Omeprazole boosts saquinavir exposure in HIV patients    Jul 22, 2008
NEW YORK (Reuters Health) - In HIV patients taking saquinavir/ritonavir, use of omeprazole leads to a significant - and apparently well tolerated - increase in saquinavir plasma exposure.
Possible biomarkers for critical limb ischemia identified    Jul 22, 2008
NEW YORK (Reuters Health) - In patients with peripheral arterial disease, levels of vascular endothelial growth factor (VEGF) and soluble Tie2 (sTie2) are increased when critical limb ischemia rather than intermittent claudication is present, new research suggests.
Sildenafil improves antidepressant-associated sexual dysfunction in women    Jul 22, 2008
NEW YORK (Reuters Health) - Sildenafil is an effective treatment for women with sexual dysfunction associated with serotonin reuptake inhibitors, according to a prospective study published in the July 23/30 issue of the Journal of the American Medical Association.
Quest profit beats expectations, shares rise    Jul 22, 2008
NEW YORK (Reuters) - Quest Diagnostics Inc, the largest U.S. medical testing company, Tuesday posted better-than-expected quarterly profit, helped by its acquisition of rival Ameripath.
Multi-drug resistance emerging in pneumococcal mastoiditis    Jul 22, 2008
NEW YORK (Reuters Health) - The Streptococcus pneumoniae serotype that most often causes mastoiditis in children is becoming increasingly drug-resistant.
Forest Labs quarterly profit beats estimates    Jul 22, 2008
NEW YORK (Reuters) - Forest Laboratories Inc reported a 9 percent decline in quarterly profit on Tuesday on higher sales and administrative costs, but results were better than expected and the company forecast fiscal-year earnings ahead of analyst projections.
Czech PPF withdraws Zentiva bid, Sanofi alone    Jul 22, 2008
PRAGUE (Reuters) - Czech financial group PPF gave up the race to take over generic drugs maker Zentiva on Tuesday, clearing the field for shareholders to weigh the merits of a competing bid from Sanofi-Aventis of France.
Depression linked with increased risk for first stroke in elderly    Jul 22, 2008
NEW YORK (Reuters Health) - A study in the July issue of Stroke suggests an association between depression and an increased risk for first-ever stroke in elderly subjects.
Direct emergency admission to catheterization lab reduces time to intervention    Jul 22, 2008
NEW YORK (Reuters Health) - Direct ambulance admission to the cardiac catheterization laboratory significantly reduces the time to performance of primary percutaneous intervention (PCI), according to a report in the June issue of the American Heart Journal.
Inhaled mannitol improves lung function in cystic fibrosis patients    Jul 22, 2008
NEW YORK (Reuters Health) - Treatment with inhaled mannitol leads to significantly improved lung function in patients with cystic fibrosis (CF), according to a report by Australian researchers in the June issue of Chest.
Analysts cut Merck target on withheld view; shares fall    Jul 22, 2008
BANGALORE (Reuters) - Leerink Swann downgraded Merck & Co Inc, while several other brokerages cut their targets on the stock Tuesday, a day after the drug maker withheld its 2008 earnings forecast after a mostly negative study on cholestrol treatment Vytorin, sending its shares down to their lowest in 2-½ years.
Strides Arcolab Q2 turns red on forex losses    Jul 22, 2008
MUMBAI (Reuters) - Drugmaker Strides Arcolab Ltd on Tuesday posted a net loss for the quarter ended June due to foreign exchange-related losses.
Goldman Sachs adds Amylin to conviction buy list    Jul 22, 2008
BANGALORE (Reuters) - Goldman Sachs replaced Gilead Sciences Inc with Amylin Pharmaceuticals Inc on its conviction buy list, citing higher upside in Amylin's stock.
Biogen profit up 11 pct, Tysabri shines    Jul 22, 2008
NEW YORK (Reuters) - Biogen Idec Inc reported a higher-than-expected second-quarter profit on Tuesday as sales of its closely watched multiple sclerosis drug Tysabri surged past Wall Street estimates, pushing its shares up more than 5 percent.
U.S. regulators reviewing latest Vytorin heart data    Jul 22, 2008
WASHINGTON (Reuters) - U.S. drug regulators said on Monday they are reviewing the latest data that found Schering-Plough Corp and Merck & Co Inc's drug Vytorin failed to improve heart outcomes in a widely-watched clinical study.
Amylin posts wider second-quarter net loss    Jul 22, 2008
LOS ANGELES (Reuters) - Amylin Pharmaceuticals Inc reported a wider quarterly loss Monday due to increased expenses as it works to develop a once-weekly diabetes treatment.
Endostatin levels reflect pancreatic cancer progression    Jul 22, 2008
NEW YORK (Reuters Health) - Endostatin levels are increased in patients with pancreatic cancer and decline after surgical treatment or chemotherapy, according to a report in the June 15th International Journal of Cancer.
GORE-TEX implants seen as safe alternative to graft for rhinoplasty    Jul 22, 2008
NEW YORK (Reuters Health) - GORE-TEX (expanded polytetrafluoroethylene) implants are a safe and inexpensive alternative to autografts for use in rhinoplasty, according to the results of a 17-year retrospective review.
Sperm motility before varicocele treatment predicts pregnancy    Jul 22, 2008
NEW YORK (Reuters Health) - In infertile men undergoing varicocele embolization, sperm motility before treatment predicts their odds of siring a pregnancy, according to a report in the August issue of Radiology.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52

53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69

70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86

87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102

103
104
105
106
107
108
109
110
111
112
113
114
115
116

117
118
119
120
121
122
123
124
125
126
127
128
129
130

131
132
133
134
135
136
137
138
139
140
141
142
143
144

145
146
147
148
149
150
151
152
153
154
155
156
157
158

159
160
161
162
163
164
165
166
167
168
169
170
171
172

173
174
175
176
177
178
179
180
181
182
183
184
185
186

187
188
189
190
191
192
193
194
195
196
197
198
199
200

201
202
203
204
205
206
207
208
209
210
211
212
213
214

215
216
217
218
219
220
221
222
223
224
225
226
227
228

229
230
231
232
233
234
235
236
237
238
239
240
241
242

243
244
245
246
247
248
249
250
251
252
253
254
255
256

257
258
259
260
261
262
263
264
265
266
267
268
269
270

271
272
273
274
275
276
277
278
279
280
281
282
283
284

285
286
287
288
289
290
291
292
293
294
295
296
297
298

299
300
301
302
303
304
305
306
307
308
309
310
311
312

313
314
315
316
317
318
319
320
321
322
323
324
325
326

327
328
329
330
331
332
333
334
335
336
337
338
339
340

341
342
343
344
345
346
347
348
349
350
351
352
353
354

355
356
357
358
359
360
361
362
363
364
365
366
367
368